Skip to main navigation Skip to search Skip to main content

Management of Malignant Pleural Mesothelioma in the Elderly Population

  • Vivek Verma
  • , Rodney E. Wegner
  • , Ethan B. Ludmir
  • , Shaakir Hasan
  • , Athanasios Colonias
  • , Surbhi Grover
  • , Joseph S. Friedberg
  • , Charles B. Simone
  • West Penn Allegheny Health System
  • University of Texas MD Anderson Cancer Center
  • University of Pennsylvania
  • University of Maryland Medical System
  • University of Maryland
  • New York Proton Center

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Background: The median age at diagnosis for malignant pleural mesothelioma (MPM) is approximately 72 years. Elderly patients pose unique management challenges because of the increased risk of therapy-related toxicities and mortality. Because there are no high-volume retrospective studies, prospective trials, or dedicated treatment recommendations for this population, this investigation addresses a major knowledge gap by examining national practice patterns and postoperative/survival outcomes in elderly MPM patients. Methods: The National Cancer Database was queried for patients aged ≥ 80 years with newly diagnosed nonmetastatic MPM. Multivariable logistic regression ascertained factors associated with observation and surgery. Kaplan–Meier analysis assessed overall survival (OS), and multivariable Cox proportional hazards modeling examined factors associated with OS. Survival was also calculated following propensity matching. Additionally, postoperative outcomes were evaluated in surgical patients. Results: Of 4526 patients, 2% received surgery and chemotherapy, 22% underwent chemotherapy alone, and 63% were observed. Respective median OS was 12.2, 9.5, and 4.1 months (p < 0.001). Differences between all groups persisted following propensity matching (all comparisons p < 0.05). For the 8% of patients who underwent specified definitive surgery (95% of whom received pleurectomy/decortication), 30- and 90-day mortality rates were 11.0% and 28.5%, respectively. The median length of postoperative hospitalization was 6 days, with 30-day readmission occurring in 7.5% of patients. Conclusions: The majority of elderly MPM patients in the US are observed, which was associated with poorer OS than chemotherapy and/or surgery. Although highly selected surgery/chemotherapy patients were associated with the longest OS, given the high biases in database studies and high perioperative mortality rates, careful patient selection for combined modality approaches in this population is imperative.

Original languageEnglish
Pages (from-to)2357-2366
Number of pages10
JournalAnnals of Surgical Oncology
Volume26
Issue number8
DOIs
StatePublished - Aug 15 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Management of Malignant Pleural Mesothelioma in the Elderly Population'. Together they form a unique fingerprint.

Cite this